For more information, read the FDA announcement or the Novartis press release.
For more information, read the FDA announcement or the Novartis press release.

Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
